MedApp, an innovative technology company listed on NewConnect, is actively monitoring funding opportunities from the National Reconstruction Plan (NTP)<\/b> for technological upgrades of Polish hospitals. The company hopes to obtain financial support from these funds to promote its advanced CarnaLife Holo technology in medical facilities. MedApp CEO David Odrakiewicz, in an interview with ISBnews, stressed the strategic importance of the domestic market for the company.<\/p>\n
“We want to be one of the beneficiaries of the multi-billion dollar outlay from the KPO fund. We will gradually offer our CarnaLife Holo technology to more hospitals, so the domestic market remains very important to us,” Odrakiewicz said.<\/p>\n
The company’s president also pointed out that, according to media reports, up to PLN 10 billion could go to some 200 Polish hospitals. “These are funds that should also upgrade the equipment base we have so far. For us as an entity offering modern medical technologies, this is quite a challenge, but also an opportunity for potentially big sales successes on the Polish market,” he said. – added the CEO.<\/p>\n
MedApp is also expanding its services into new medical specialties, including dentistry. \u201eNowy segment to stomatologia, gdzie przy bardziej skomplikowanych zabiegach lekarze mog\u0105 skorzysta\u0107 z naszego obrazowania 3D\/4D. W tym konkretnym przypadku bardziej liczymy na klient\u00f3w zagranicznych, cho\u0107 jak wspomnia\u0142em, jest to rozwi\u0105zanie uniwersalne dla wszystkich wi\u0119kszych klinik stomatologicznych\u201d \u2013 wyja\u015bni\u0142 Odrakiewicz.<\/p>\n
The key market for MedApp remains the United States<\/b>. W maju br. firma za\u0142o\u017cy\u0142a tam sp\u00f3\u0142k\u0119 zale\u017cn\u0105 MedApp USA Inc. wsp\u00f3lnie z partnerem Habeelem Gazim. MedApp planuje osi\u0105gn\u0105\u0107 pierwsze sukcesy operacyjne jeszcze w tym roku. \u201ePodtrzymujemy te deklaracje. Najbli\u017csze tygodnie na ameryka\u0144skim rynku maj\u0105 by\u0107 dla nas udane\u201d \u2013 podkre\u015bli\u0142 prezes.<\/p>\n
The company also plans to expand its CarnaLife Holo product with another FDA<\/b> certification, related to the use of the technology for intraoperative procedures. \u201ePlanujemy z\u0142o\u017cy\u0107 wniosek o kolejny certyfikat FDA do ko\u0144ca bie\u017c\u0105cego roku\u201d \u2013 zapowiedzia\u0142 Odrakiewicz.<\/p>\n
MedApp is a company offering innovative, unique software solutions for next-generation diagnostic imaging and digital medicine. Its technologies, based on artificial intelligence, mixed reality and 3D imaging, are used in a wide range of medical fields, such as cardiology, diabetology, oncology surgery and many others.<\/p>\n
MedApp – Empowering people for better health.<\/p>\n","protected":false},"excerpt":{"rendered":"
“We want to be one of the beneficiaries of the multi-billion dollar outlay from the KPO fund. We will gradually offer our CarnaLife Holo technology to more hospitals, so the domestic market remains very important to us.” […]<\/p>\n